Sugammadex Dosing for a 68 kg Female
The appropriate sugammadex dose for a 68 kg female depends entirely on the depth of neuromuscular blockade at the time of reversal, ranging from 15 mg (0.22 mg/kg) for very shallow blockade to 544 mg (8 mg/kg) for immediate reversal.
Dosing Algorithm Based on Neuromuscular Blockade Depth
The critical principle is that sugammadex dosing must be guided by objective neuromuscular monitoring—the dose cannot be determined without first assessing the degree of blockade 1. Each sugammadex molecule encapsulates only one molecule of rocuronium or vecuronium, so deeper blockade requires proportionally more sugammadex.
Specific Doses for 68 kg Patient:
For Very Shallow Blockade (TOF ratio ≥ 0.5):
- Dose: 15 mg (0.22 mg/kg)
- Achieves TOF ratio > 0.9 in < 5 minutes in 95% of patients 1
For Moderate Blockade with 4 TOF Responses:
- Dose: 68 mg (1.0 mg/kg)
- Reverses blockade in < 5 minutes 1
- Alternative: 34 mg (0.5 mg/kg) is effective but slower (10 minutes) 1
For Moderate Blockade with 2 TOF Responses:
- Dose: 136 mg (2.0 mg/kg minimum)
- Reverses blockade in < 5 minutes 1
For Deep Blockade (PTC 1-2 responses, no TOF responses):
- Dose: 272 mg (4.0 mg/kg)
- Achieves TOF ratio ≥ 0.9 in 3-5 minutes 1
For Very Deep Blockade/Immediate Reversal (no PTC responses or 3-15 min after high-dose rocuronium):
- Dose: 544 mg (8.0 mg/kg)
- Achieves TOF ratio ≥ 0.9 in 3-5 minutes 1
Critical Considerations
Weight-Based Dosing
Sugammadex should be dosed according to ideal body weight 1. The guideline explicitly states this as a Grade 1+ recommendation with strong agreement 1. For a 68 kg female, if this represents actual body weight and is within normal BMI range, use actual weight. For obese patients, ideal body weight is appropriate 2.
Monitoring is Mandatory
Continued neuromuscular monitoring after sugammadex administration is essential to detect potential recurarization 1. Inadequate dosing is the primary cause of recurarization 1. The guidelines recommend quantitative monitoring with Grade 2+ strength 1.
Special Populations
- Elderly patients: Sugammadex efficacy is decreased; may require higher doses or longer recovery times 1
- Severe renal impairment (CrCl < 30 mL/min): Efficacy significantly reduced, especially for deep blockade reversal 1, 3
Common Pitfalls to Avoid
- Never administer sugammadex without knowing the blockade depth—this is the most common error and can lead to inadequate reversal or unnecessary overdosing
- Do not assume reversal is complete without objective confirmation—clinical assessment alone is insufficient 4
- Avoid underdosing at deep blockade levels—using 2 mg/kg when 4 mg/kg is needed will result in delayed or incomplete reversal
- Do not discontinue monitoring after administration—recurarization can occur with inadequate dosing 1
The evidence consistently demonstrates that appropriate sugammadex dosing requires a systematic approach: assess blockade depth → select corresponding dose → administer → continue monitoring until TOF ratio ≥ 0.9 is confirmed 1.